✓Strengths
- Low debt: debt-to-equity of 0.33.
- Comfortable interest cover: operating profit covers interest about 79.9 times.
- Return on equity is healthy at 16.7%.
- Return on capital employed is healthy at 17.9%.
- Net profit margin is strong at 15.4%.
- Current assets comfortably cover current liabilities (current ratio 3.47).
- Profit has compounded about 108% a year over five years.
- Pays a dividend (yield about 5.2%).
- Has paid a dividend in each of the last 5 years on record.
!Watch-points
- Sales growth has been slow over five years (about -9% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.69
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the market-value term.
Piotroski F-ScoreModerate
4 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Book Value₩ 25,695.22
Dividend Yield5.20%
ROCE17.88%
ROE16.68%
Debt to Equity0.33
Current Ratio3.47
EPS₩ 4,248.00
PAT Margin15.44%
ICR79.87
Compounded Sales Growth
10 Years
—
5 Years
-9.24%
3 Years
—
TTM
—
Compounded Profit Growth
10 Years
—
5 Years
107.71%
3 Years
—
TTM
—
Stock Price CAGR
10 Years
—
5 Years
—
3 Years
—
1 Year
—
Return on Equity
10 Years
—
5 Years
—
3 Years
—
Last Year
16.68%